FindTrial
Sign In

The treatment status and risk factors related to prognosis of hospitalized patients with novel coronavirus pneumonia (COVID-19) in intensive care unit, Hebei, China: a descriptive study

The treatment status and risk factors related to prognosis of hospitalized patients with novel coronavirus pneumonia (COVID-19) in intensive care unit, Hebei, China: a descriptive study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030226
Enrollment
Unknown
Registered
2020-02-26
Start date
2020-02-01
Completion date
Unknown
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:Nil

Sponsors

The Fourth Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients with 2019 novel coronavirus–infected pneumonia enrolled in this study were diagnosed according to guidance(trial version 5) of China,and met the standard of Heavy or critically ill.

Exclusion criteria

Exclusion criteria: Pregnancy;Sudden death disease, such as fatal heart disease patients.

Design outcomes

Primary

MeasureTime frame
Clinical characteristics;—

Countries

China

Contacts

Public ContactZhenjie Hu

The Fourth Hospital of Hebei Medical University

syicu@vip.sina.com+86 13933856908

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026